Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Chemistry & Biology
|
July 29, 2014
Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes
Chia-Hung Christine Hsiao, Xiaochen Lin, Rocky J Barney, et al.
Bioorganic & Medicinal Chemistry
|
July 23, 2021
Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors
Alisa E R Fairweather, Daniel B Goetz, Chloe M Schroeder, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2022
Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold
Nyema M Harmon, Michael M Poe, Xueting Huang, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 28, 2015
Evaluation of a 7-Methoxycoumarin-3-carboxylic Acid Ester Derivative as a Fluorescent, Cell-Cleavable, Phosphonate Protecting Group
Andrew J Wiemer, Rebekah R Shippy, Ashley M Kilcollins, et al.
Bioorganic & Medicinal Chemistry
|
July 12, 2017
Selective opioid growth factor receptor antagonists based on a stilbene isostere
David P Stockdale, Michelle B Titunick, Jessica M Biegler, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 2008
Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation
Andrew J Wiemer, Jose S Yu, Larry W Shull, et al.
Bioorganic & Medicinal Chemistry
|
March 5, 2025
Impact of fixed phosphorus position on activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors
Md Ayub Ali, Mona A Maalouf, Dan Feng, et al.
Phytochemistry
|
August 19, 2008
Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction
Kimberly D P Hammer, Matthew L Hillwig, Jeffrey D Neighbors, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner
Thomas J Turbyville, Demirkan B Gürsel, Robert G Tuskan, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol
Nicholas A Lentini, Chloe M Schroeder, Nyema M Harmon, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Chemistry & Biology
|
July 29, 2014
Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes
Chia-Hung Christine Hsiao, Xiaochen Lin, Rocky J Barney, et al.
Bioorganic & Medicinal Chemistry
|
July 23, 2021
Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors
Alisa E R Fairweather, Daniel B Goetz, Chloe M Schroeder, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2022
Synthesis and Metabolism of BTN3A1 Ligands: Studies on Diene Modifications to the Phosphoantigen Scaffold
Nyema M Harmon, Michael M Poe, Xueting Huang, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 28, 2015
Evaluation of a 7-Methoxycoumarin-3-carboxylic Acid Ester Derivative as a Fluorescent, Cell-Cleavable, Phosphonate Protecting Group
Andrew J Wiemer, Rebekah R Shippy, Ashley M Kilcollins, et al.
Bioorganic & Medicinal Chemistry
|
July 12, 2017
Selective opioid growth factor receptor antagonists based on a stilbene isostere
David P Stockdale, Michelle B Titunick, Jessica M Biegler, et al.
Bioorganic & Medicinal Chemistry
|
March 1, 2008
Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation
Andrew J Wiemer, Jose S Yu, Larry W Shull, et al.
Bioorganic & Medicinal Chemistry
|
March 5, 2025
Impact of fixed phosphorus position on activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors
Md Ayub Ali, Mona A Maalouf, Dan Feng, et al.
Phytochemistry
|
August 19, 2008
Pseudohypericin is necessary for the light-activated inhibition of prostaglandin E2 pathways by a 4 component system mimicking an Hypericum perforatum fraction
Kimberly D P Hammer, Matthew L Hillwig, Jeffrey D Neighbors, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner
Thomas J Turbyville, Demirkan B Gürsel, Robert G Tuskan, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Synthesis and Metabolism of BTN3A1 Ligands: Studies on Modifications of the Allylic Alcohol
Nicholas A Lentini, Chloe M Schroeder, Nyema M Harmon, et al.
Page
of 11